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1. Introduction 
Although the morphologic aspects of mitosis have 
been studied for over a hundred years [I], the 
molecular mechanisms underlying the progression of
mitotic events are virtually unknown. Considerable 
insight into the process of mitotic induction has been 
gained by the observation that when a mitotie cell is 
fused with an interphase cell (mediated via Sendai 
virus), the interphase cell nuclear membrane breaks 
down and the chromosomes condense [2 1. These 
classic experiments imply that factors from the mitotic 
cell are able to induce mitosis in the non-mitotic ell. 
Obvious questions arising from these exper~ents 
concern the nature and mode of action of the mitotic 
inducing factors. To answer such questions, amethod 
for assaying the activity of factors from mitotic cells 
was needed. The immature frog oocyte provides uch 
an assay [3]; extracts from early cleavage frog 
embryos during mitosis stimulate the meiotic matura- 
tion of the immature frog oocyte. Extracts of HeLa 
cells in mitosis also induce meiotic maturation in the 
frog oocyte [4]. We too, have used cytoplasmic 
extracts of mammalian cells to induce meiotic matura- 
tion in X. Iaevis oocytes. We show here that the active 
component(s) isprobably a protein(s); the protein(s) 
is mol. wt >I0 000, is calcium sensitive and is quite 
heat labile. This protein(s) will induce maturation in 
the absence of protein or RNA synthesis n the oocyte. 
Finally, we show that the protein(s) is dramatically 
stabilized by agents that inhibit phosp~ta~s, uggest- 
ing that phosphoq lation-dephospho~lation events 
may be important in the control of mitotic induction. 
2. Materials and methods 
2.1 . Materials 
Dulbecco’s modified Eagle’s medium was purchased 
from Microbiological Associates (Rockville, MD) and 
fetal calf serum from Sterile Systems (Logan, UT). 
Papain, antipain, actinomycin D, cycloheximide, 
progesterone and RNase were from Sigma Chemical 
Co. (St Louis, MO). DNase was from Worthington 
Biochemicals (Freehold, NJ). 
2.2. Preparation of mitotic and interphase ceils 
The CHO-Kl line of Chinese hamster ovary cells 
was obtained from the ~eric~-Ty~ Culture 
Collection (Rockville, MD) and grown in DuIbecco’s 
modified Eagle’s medium supplemented with proline 
(34 mg/l), HEPES (25 mM), penicillin (100 tighnl), 
streptomycin (100 pg/ml), and 10% fetal calf serum 
~ME-10). Cells were synchron~ed by a slight modifi- 
cation of a procedure developed for sync~onization 
of CHO cells [5,6]. Briefly, cells at 1.5 X 105/cm2 
were blocked in Gl by isoleucine starvation for 44 h, 
then released into DME-IO containing hydroxyurea 
(2 mM) for 9 h to synchronize them at the Cl/S 
bounds. The media was then replaced with fresh 
DME-10, and Colcemid was added 12 h later. After 
3 h more, metaphase cells were cohected by gently 
shaking the loosely adherent mitotic cells from the 
culture dish. The mitotic index of these cells was 
>98%. Interphase cells were prepared by trypsiniza- 
tion of monolayer cultures. 
2.3. Preparation of cell extracts 
All steps were performed at 0°C. Cells were 
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washed once in Hank’s balanced salt solution with 
10 mM MgClz without calcium. Cells were then 
suspended (10’ cells/ml) in extraction buffer con- 
taining 200 mM NaCl, 200 mM sucrose, 2 mM EGTA, 
10 mM MgCl*, 10 mM sodium phosphate (pH 6.7). 
This buffer had previously been shown to be effective 
for preparing meiotic induction factors from unfer- 
tilized frog eggs [7]. The suspension was sonicated for 
4 s at 0°C with a Heat Systems sonicator (Plainview, 
NY), using a microprobe setting of 70 W output. The 
mixture was then centrifuged for 20 min at 27 000 X g 
in a Sorvall SS-34 rotor. The supernatant was filtered 
through a GF/C filter (Whatman) to remove any 
particulate matter, and was then used for injection. 
2.4. Oocy te assay 
Oocytes were obtained from X. laevis femdes 
from South Africa supplied by a local distributor. 
Individual oocytes of >1.2 mm diam. were dissected 
out manually. In some experiments, the ovary was 
treated for 3-4 h with collagenase (Calbiochem B 
grade) in amphibian Ringer’s solution without calcium 
before dissection. Oocytes were kept in amphibian 
Ringer’s solution (with calcium) and injected with 
70 nl fluid. After 3 h, meiotic maturation was assessed 
in the injected oocytes. The assay consisted of obser- 
vation for the appearance of a white ‘maturation spot’ 
centered at the animal pole and the disappearance of 
the germinal vesicle (nucleus). The white maturation 
spot represents pigment displaced by the movement 
of the germinal vesicle towards the animal pole [8]. 
The presence or absence of the germinal vesicle was 
determined after fixation of the oocytes in 5% tri- 
chloroacetic acid. Some oocytes were fixed in Smith’s 
fluid, embedded in paraffin, sectioned, and stained 
with Feulgen or Unna to examine the state of the 
chromosomes. 
3. Results 
When a cytoplasmic extract prepared from mitotic 
cells is injected into immature oocytes, 100% of the 
oocytes undergo meiotic maturation (table 1). The signs 
of maturation always appeared between 1.75-2.25 h 
after injection of mitotic cell extract. These signs 
included a white spot centered at the animal pole and 
germinal vesicle breakdown (see section 2). Histological 
studies showed that the chromosomes had condensed 
on a spindle near the oocyte cortex in the animal 
hemisphere. Hence, true maturation, rather than 
pseudomaturation [9], was induced. 
Control experiments showed that extracts iden- 
tically prepared from interphase cells did not induce 
maturation. This was true whether the interphase 
cells were in logarithmic growth or had been pre- 
Table 1 
Meiotic maturation in oocytes treated with extracts of CHO cells 
Material injecteda No. of oocytes injected Meiotic maturation (%) 
Mitotic ceU extract 
Mitotic cell extract diluted 1: 1 
Mitotic ceU extract diluted 1:2 
Mitotic ceU extract diluted 1:4 
Mitotic cell extract diluted 1: 10 
Interphase cell extractb 
S phase ceU extractC 
Interphase cell extract 
(Colcemid treated)d 
Extraction buffer only 
Cytoplasm from mature oocytese 
50 
16 
16 
16 
16 
30 
16 
16 
40 
16 
100 
100 
100 
50 
6 
0 
0 
0 
5 
100 
a All extracts prepared with 10’ cells/ml. Where indicated, extract was diluted with 
extraction buffer 
b Obtained from an exponentially growing celJ population 
c Cells were synchronized in S phase by isoleucine deprivation and hydroxyurea treat- 
ment followed by a 6 h growth period in DME-10 
d Exponentially growing cells were treated with Colcemid for 3 h. The cells remaining 
after detaching the mitotic cells were used to prepare the extract 
e Oocytes were matured in vitro by exposure to progesterone, 10 &ml, for 15 min 
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treated with isoleucine deficient medium and hydroxy- 
urea, or Colcemid (table 1). Cytoplasm from progeste- 
rone matured oocytes served as a positive control in 
induction of meiotic maturation. Extraction buffer 
alone never induced a full meiotic maturation (i.e., 
complete with white spot and condensed chromo- 
somes adjacent to cortex), but sometimes induced a 
small percentage of injected oocytes (<5%) to undergo 
germinal vesicle breakdown, perhaps due to damage 
by the injection needle. 
We next inquired as to whether the mitotic fac- 
tors were active if RNA or protein synthesis was 
inhibited in the injected oocyte. It is known that 
cytoplasm from mature oocytes or cleaving embryos 
will induce meiotic maturation in the absence of 
protein or RNA synthesis [3,10,11], but protein 
synthesis inhibitors block progesterone maturation 
[9,11,12]. The data in table 2 show that CHO mitotic 
cell extract is active in the presence of cycloheximide 
or actinomycin D. Therefore, the active components 
in CHO mitotic cell extract must bypass ome step 
involving protein synthesis required for progesterone- 
induced maturation. This is consistent with the fact 
that maturation induced by CHO mitotic cell extract 
occurs l-75-2.25 h after injection,while progesterone- 
induced maturation takes 4-12 h. 
We next investigated the nature of the components 
responsible for the activity of mitotic cell extracts. 
Table 3 shows that the active factor(s) is quite heat 
labile, e~ibiting no activity after a 2 h incubation at 
37’C. The active factor(s) behaved as a molecule of 
mol. wt >lO 000 upon dialysis. In addition, the factor 
was sensitive to calcium, losing al.l activity in the 
presence of 10 mM calcium. 
One of the most interesting characte~stics examined 
was the increased stability of the active factor(s) 
when the extract was maintained in a buffer designed 
to inhibit phosphatases (consisting of 1.50 mM NaCl, 
25 mM NaF, 2 mM EGTA, 50 mM P-glycerophos- 
phate, 1 mM ATP, pH 6.6). In phosphatase inhibiting 
buffer, the extract was active for >6 days (at O’C), 
while mitotic extract in the original extraction buffer 
lost all of its activity after 6-12 h. On the basis of 
this increased stability, we now prepare xtract by 
sonicating mitotic cells in phosphatase inhibiting 
buffer rather than extraction buffer. These experi- 
ments were suggested by the finding [ 131 that phos- 
phatase inhibitors would prolong the stability of cyto- 
plasmic factors from in vitro matured oocytes; such 
buffers also stabilize the activity of extracts prepared 
from cleaving frog embryos (Wasserman, personal 
communication). 
We then tested whether the heat sensitivity of the 
mitotic inducing factor(s) was due to activation of 
phosphatases inherently present in the extract. As 
shown in table 4, the factor(s) was still heat sensitive 
(37’C, 6 h) in the presence of phosphatase inhibiting 
buffer. This suggests hat activation of phosphatases 
is not the cause of the heat sensitivity; however, the 
possibility that phosphatase inhibiting buffer does 
not completely inhibit phosphatase activity at 37’C 
cannot be ruled out at present. 
Finally, we showed that the active mitotic factor(s) 
was protein dependent as demonstrated by its sen- 
sitivity to papain. Papain was chosen because it is a 
protease that can be used at room temperature in the 
presence of EGTA and because it is readily inhibited 
by antipain; active proteases are toxic to frog oocytes 
Table 2 
Effect of protein and RNA synthesis inhibitors on activity of mitotic extract 
Inducing agent Treatment of oocytes % Meiotic maturationa 
Mitotic cell extract None 100 
Mitotic cell extract Cyclohex~ideb 100 
Mitotic cell extract Actinomycin Db 100 
Progesterone’ None 100 
Progesterone Cycloheximideb 12 
Progesterone Actinomycin Db 94 
a 16 oocytes were used for each experiment 
b Cycloheximide (40 &g/ml) or actinomycin D (SO pgfml) were present in the 
amphibian Ringer’s solution bathing the oocytes from 2 h prior to treatment 
with the inducing agent until fixation of the oocytes 
c Oocytes were treated with progesterone (10 &ml) for 15 mm and fixed 12 h 
later 
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Table 3 
Effects of various treatments of mitotic cell extracts on the induction of 
meiotic maturation 
Treatment of extract % Meiotic maturationa 
None 100 
Heated to 37’C for 2 h 0 
Dialysis? 100 
Calcium addedC 0 
Papain treatedd 10 
Papain buffer onlye 100 
Ammonium sulfate, O-20% precipitatef 0 
Ammonium sulfate, 20-40% precipitatef 100 
Ammonium sulfate, 40-60% precipitatef 10 
Ammonium sulfate, 60-100% precipitatef 0 
a 10 oocytes were injected in each experiment 
b Mitotic cell extract was dialyzed in a Schleicher and Schuell (Keene, NH) collo- 
dion bag (exclusion limit of mol. wt 10 000) against extraction buffer to a total 
dilution of iOr 
c Mitotic cell extract was dialyzed as above in extraction buffer (without EGTA) 
containing 10 mM CaCl, 
d Mitotic cell extract was treated with papain (500 &g/ml) in phosphatase inhibit- 
ing buffer containing cysteine (5 mM) and P-mercaptoethanol(O.05 mM) for 
1 h at 25’C. Antipain (80 fig/ml) was then added for 10 min at 25’C before 
injection 
e Extract was incubated 1.25 h at 25*C in phosphatase in~bit~g buffer contain- 
ing cysteine (5 mM) and ~-mer~ptoethanol(O.06 mM) before injection 
f Saturated ammonium suJfate (0.25 vol.) was added to 1 vol. extract at 0°C. The 
resulting precipitate was centrifuged, resuspended in phosphatase inhibiting 
buffer and dialyzed against phosphatase inhibiting buffer before injection. More 
ammonium sulfate wasadded to the supernatant, and the above process repeated 
to get the fractions indicated in the table 
Table 4 
Effects of phosphatase inhibitors on stability of mitotic ceB extracts 
Treatment of mitotic cell extracta % Meiotic maturationb 
None 
0” ,20 h in extraction bufferC 
0”) 20 h in phosphatase ~hibitin8 bufferd 
0” , 144 h in phosphatase inhibiting bufferd 
37”C, 2 h in phosphatase inhibiting bufferd 
Phosphatase inhibiting buffer (no extract) 
100 
10 
100 
100 
10 
0 
a Extracts were originally prepared in extraction buffer 
b 10 oocytes were injected in each experiment 
c Extract was dialyzed against extraction buffer (final dilution 1 O6 over 6 h) before 
incubation at 0°C 
d Extract was dialyzed against phosphatase inhibiting buffer (final dilution lo6 
over 6 h) before incubation at the indicated temperatures 
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(B. Vogelstein, unpub~~ed ata). When mitotic cell 
extract was treated with papain, and the papain sub- 
sequently inhibited with antipain, no meiotic matura- 
tion inducing activity remained (table 3). Control 
experiments showed the amount of antipain used was 
sufficient o inhibit all papain activity. Other control 
experiments showed that mitotic cell extract incu- 
bated at 25’C for 1.25 h in the buffer used for papain 
treatment retained its activity. Treatment with 
RNase and DNase (covalently attached to beads) did 
not inhibit the activity of the mitotic cell extract 
(data not shown). 
It is also shown in table 4 that the active factor is 
precipitable with ammonium sulfate at 20-40% 
saturation. This provides a small (3-fold) purification, 
as measured by protein determination [14]. This 
recovery of activity after ammonium sulfate precipi- 
tation was not possible in the original extraction 
buffer which did not contain phosphatase inhibitors. 
4. Discussion 
The above results how that mitotic CHO cell 
extracts consistently induce meiotic maturation in 
immature X. iaevis oocytes, while extracts identically 
prepared from interphase cells do not. The data in 
tables 3,4 show that the active component in these 
mitotic extracts is papain sensitive, isprobably of 
mol. wt >lO 000, is heat sensitive and precipitable 
with ammonium sulfate, and stabilized with phos- 
phatase inhibiting reagents. All these data are con- 
sistent with the interpretation that the active com- 
ponent is a protein [7]. We have tentatively termed 
this protein(s) from mitotic CHO cells MIP, mitotic 
inducing protein(s). Although the assay for its activity 
is induction of meiotic maturation, it seems reason- 
able to assume that its natural function in the CHO 
cell is to induce mitosis. 
Biological evidence indicates that the initiating 
events in mitosis and meiosis must have some features 
in common; mitotic cell extracts induce meiosis in 
frog oocytes ([3,4] this work), and meiotic cell 
cytoplasm induces mitosis in interphase nuclei [ 15,161. 
This work indicates that, similarly, the factor(s) 
vitiating mitosis has physical properties in common 
with the factors characte~ed [7,13] initia~ng 
meiosis from frog oocytes. Both factors are Cap sen- 
sitive, heat-labile proteins which are stabilized by 
phosphatase inhibitors. it is noteworthy that these 
similarities extend between species as evolution~y 
diverse as frog and hamster. 
The results in table 4 indicate that reagents which 
are known to inhibit phosphatases (NaF, fl-glycero- 
phosphate, ATP) stabilize the activity of MIP. How- 
ever, these agents exert many diverse ffects besides 
the inhibition of phosphatases and ATPase [ 13,17-2 11. 
A variety of studies have suggested that phosphoryla- 
tion may play a role in meiosis [13,22-241. It is 
intriguing to speculate on the possiblity that phos- 
pho~Iation-dephospho~lation reactions might be 
involved in the induction and cessation of mitotic 
events. Definitive evidence to support such specula- 
tion must await the further purification of MIP. 
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